Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 366452-97-3 | MDL No. : | MFCD09701290 |
Formula : | C8H6N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RTDDSWLIZLMORY-UHFFFAOYSA-N |
M.W : | 178.14 | Pubchem ID : | 21961387 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 50.22 |
TPSA : | 74.92 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.96 cm/s |
Log Po/w (iLOGP) : | 0.86 |
Log Po/w (XLOGP3) : | 0.6 |
Log Po/w (WLOGP) : | 0.31 |
Log Po/w (MLOGP) : | 0.04 |
Log Po/w (SILICOS-IT) : | -0.36 |
Consensus Log Po/w : | 0.29 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.6 |
Solubility : | 4.5 mg/ml ; 0.0252 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.75 |
Solubility : | 3.19 mg/ml ; 0.0179 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.27 |
Solubility : | 0.961 mg/ml ; 0.0054 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With ammonium formate In methanol at 35℃; for 2 h; | A mixture of 4-nitro-2,3-dihydro-lH-isoindol-l-one (2Og), ammonium formate (35g) and 7.5percent Pd/C( 0.6g) in methanol (60ml) was stirred for 2 hours by heating up to 35°C . Pd/C was filtered and the filtrate concentrated under reduced pressure. The residue was recrystallized from water to give 15.3g of light yellow solid, yield: 92percent. mp: 195.6-197°C .1H-NMR: (300MHz, DMSO-dβ) δ: 4.3 l(s, 2H), 6.76(d, IH), 7.14(t, IH), 6.86(d, IH), 5.30(s, 2H), 8.26(s, IH)1H-NMR: (300MHz, DMSO-dβ/ D2O) δ: 4.14(s, 2H), 6.79(d, IH), 6.93(d, IH), 7.16(t, IH)FAB(M+1): 149 Element analysis: theoretical data: C 64.85percent, H 5.44percent, N 18.91percent measured data: C 64.96percent, H 5.61percent, N 19.02percent Test condition of HPLC: type and specification of column: phenomenex Luna 5u Cl 8250mmχ4.6mm; velocity: l .Oml/min; λ=230nm mobile phase: acetonitrile/0.1percentphosphate = 15/85 or acetonitrile/O.OIMammonium acetate = 10/90 appearance time of tar get yield: 3.580minutes ; 4.790minutes purity of target yield: 99.66percent |
83% | With ammonium formate In N,N-dimethyl-formamide | d Synthesis of 4-amino-2,3-dihydro-1H-isoindol-1-one (4): To a solution of 4-nitro-2,3-dihydro-1H-isoindol-1-one (compound 3, 3.2 gm, 0.018 mmol.) in DMF (10 ml), was added ammonium formate (5.750 gm), and Pd-C (100 mg), and the reaction mixture was stirred at 100° C. for 30 min. The mixture was then filtered through a pad of celite, and the celite was washed with DMF (10 ml) and water (10 ml). The filtrate was concentrated under vacuum to give compound 4 (2.2 gm, 83percent). 1NMR (DMSO-D6): 4.20 (s, 2H, CH2), 5.20 (bs, NH2), 6.82 (dd,1H, Ar-H), 7.02 (dd,1H, Ar-H), 7.16 (t,1H, Ar-H), 8.20 (bs,1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With ammonia In methanol at 20℃; for 2.5 h; | A mixture of methyl 2-bromomethyl-3-nitrobenzoate (2Og) and methanol (200ml) was stirred under ammonia gas for 30 min at room temperature, and was kept in heat preservation for 2 hours. Crystal grew in an ice bath for 2 hours, and then filtered, and dried to give 11.7g of light yellow crystal, yield: 90percent. mp: 235.4~236.7°C .1H-NMR: (300MHz, DMSO-dβ) δ: 4.78(s, 2H), 7.79(t, IH), 8.10(d, IH), 8.41(d, IH), 8.90(S, IH).1H-NMR: (300MHz, DMSO-dβ/EhO) δ: 4.76(s, 2H), 7.77(t, IH), 8.08(d, IH), 8.39(d, IH). FAB(M+1): 179 Element analysis: theoretical data: C 53.94percent, H 3.39percent, N 15.72percent measured data: C 54.08percent, H 3.49percent, N 15.81percent Test condition of HPLC: type and specification of column: phenomenex Luna 5u Cl 8250mmχ4.6mm; velocity: l .Oml/min; λ=230nm mobile phase: acetonitrile /0.1percent phosphate = 30/70 appearance time of target yield : 5.810 minutes purity of target yield: 99.59percent |
[ 41663-84-7 ]
2-Methyl-5-nitroisoindoline-1,3-dione
Similarity: 0.88
[ 21091-98-5 ]
(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone
Similarity: 0.85
[ 41663-84-7 ]
2-Methyl-5-nitroisoindoline-1,3-dione
Similarity: 0.88
[ 21091-98-5 ]
(4-Methylpiperazin-1-yl)(4-nitrophenyl)methanone
Similarity: 0.85
[ 41663-84-7 ]
2-Methyl-5-nitroisoindoline-1,3-dione
Similarity: 0.88
[ 19171-18-7 ]
2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione
Similarity: 0.81